Relmada Therapeutics Cash from Investing (TTM) Trends

Relmada Therapeutics Inc (RLMD)

3.68 -0.04 (-1.08%) USD | NASDAQ | May 03, 16:00

3.66 -0.02 (-0.54%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	50.45M
September 30, 2023	41.06M
June 30, 2023	68.75M
March 31, 2023	69.76M
December 31, 2022	19.73M
September 30, 2022	-69.79M
June 30, 2022	-73.84M
March 31, 2022	-79.61M
December 31, 2021	-54.12M
September 30, 2021	38.00M
June 30, 2021	15.08M
March 31, 2021	4.650M
December 31, 2020	-34.45M
September 30, 2020
June 30, 2020
March 31, 2020
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018

Date	Value
September 30, 2018
June 30, 2018	-0.0124M
March 31, 2018	-0.0048M
December 31, 2017	-0.025M
September 30, 2017	-0.0275M
June 30, 2017	-0.0497M
March 31, 2017	-0.0705M
December 31, 2016	-0.1134M
September 30, 2016	-0.5858M
June 30, 2016	-0.5623M
March 31, 2016	-0.5431M
December 31, 2015	-0.4823M
September 30, 2015	-0.014M
June 30, 2015	-0.0233M
March 31, 2015	-0.0195M
December 31, 2014	-0.0172M
September 30, 2014	-0.0107M
February 28, 2014	-0.0018M
November 30, 2013	-0.0018M
August 31, 2013	-0.0018M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-79.61M

Minimum

Mar 2022

69.76M

Maximum

Mar 2023

-0.3324M

Average

15.08M

Median

Jun 2021

Cash from Investing (TTM) Benchmarks